Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Baigent

Showing results (51-60 of 171) with videos related to

Pageof 18
Sort By:
BMJ (Clinical Research Ed.)|June 3, 2006
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsPatricia M Kearney, Colin Baigent, Jon Godwin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 28, 2019
Chronic kidney disease, heart failure and neprilysin inhibitionRichard Haynes, Doreen Zhu, Parminder K Judge, et al.
Heart (British Cardiac Society)|February 26, 2025
Balancing the risk of major bleeding against vascular disease risk in people without atherosclerotic diseaseImen Hammami, Marion Mafham, Jonathan Emberson, et al.
Lancet (London, England)|August 1, 2014
Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial, Richard Haynes, Paul Harden, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 14, 2019
Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKDJulio Alejandro Lamprea-Montealegre, Natalie Staplin, William G Herrington, et al.
Journal of Hypertension|March 13, 2024
A blunted nocturnal blood pressure decline is associated with all-cause and cardiovascular mortalityAlejandro de la Sierra, Natalie Staplin, Luis M Ruilope, et al.
Clinical Trials (London, England)|February 20, 2008
Sensible guidelines for the conduct of large randomized trialsSalim Yusuf, Jackie Bosch, Philip J Devereaux, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 5, 2014
Use of gel-based separator tubes to stabilise phosphate in mailed blood samplesWilliam Herrington, Sarah Clark, Natalie Staplin, et al.
Nephron. Clinical Practice|May 25, 2007
A practical method of measuring glomerular filtration rate by iohexol clearance using dried capillary blood spotsMarion M Mafham, Ioana Niculescu-Duvaz, Jeffrey Barron, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 25, 2016
Use of Causal Diagrams to Inform the Design and Interpretation of Observational Studies: An Example from the Study of Heart and Renal Protection (SHARP)Natalie Staplin, William G Herrington, Parminder K Judge, et al.
Pageof 18

Showing results (51-60 of 171) with videos related to

Sort By:
Pageof 18
BMJ (Clinical Research Ed.)|June 3, 2006
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsPatricia M Kearney, Colin Baigent, Jon Godwin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 28, 2019
Chronic kidney disease, heart failure and neprilysin inhibitionRichard Haynes, Doreen Zhu, Parminder K Judge, et al.
Heart (British Cardiac Society)|February 26, 2025
Balancing the risk of major bleeding against vascular disease risk in people without atherosclerotic diseaseImen Hammami, Marion Mafham, Jonathan Emberson, et al.
Lancet (London, England)|August 1, 2014
Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial, Richard Haynes, Paul Harden, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 14, 2019
Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKDJulio Alejandro Lamprea-Montealegre, Natalie Staplin, William G Herrington, et al.
Journal of Hypertension|March 13, 2024
A blunted nocturnal blood pressure decline is associated with all-cause and cardiovascular mortalityAlejandro de la Sierra, Natalie Staplin, Luis M Ruilope, et al.
Clinical Trials (London, England)|February 20, 2008
Sensible guidelines for the conduct of large randomized trialsSalim Yusuf, Jackie Bosch, Philip J Devereaux, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 5, 2014
Use of gel-based separator tubes to stabilise phosphate in mailed blood samplesWilliam Herrington, Sarah Clark, Natalie Staplin, et al.
Nephron. Clinical Practice|May 25, 2007
A practical method of measuring glomerular filtration rate by iohexol clearance using dried capillary blood spotsMarion M Mafham, Ioana Niculescu-Duvaz, Jeffrey Barron, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 25, 2016
Use of Causal Diagrams to Inform the Design and Interpretation of Observational Studies: An Example from the Study of Heart and Renal Protection (SHARP)Natalie Staplin, William G Herrington, Parminder K Judge, et al.
Pageof 18